72% of Florida Business Leaders Say Biotech is Florida's Next Innovation Boom, According to Foley Flash Poll
May 5, 2008
Despite Importance of Intellectual Property in Biotech Growth, One in Three Still Classify Their IP Strategy as “Defensive/Reactive”
A flash poll of business leaders at a recent Foley conference revealed insights into where the state is likely headed in terms of business growth – with 72 percent indicating that biotech will see the most significant growth in the next two years. However, despite the role a strong Intellectual Property (IP) strategy will play in the growth of these areas, 36 percent of respondents characterized their company’s approach to IP as “defensive/reactive.”
Click here to download the press release
Related Insights
March 11, 2026
Manufacturing Industry Advisor
How Supply Chain Mapping Strengthens Supply Chain Integrity
The last six years have brought vast changes in the U.S. regulatory landscape (e.g., tariff volatility, new supply chain integrity rules), unprecedented raw material shortages, and a global pandemic, just to list a few high-profile examples. This has led to unprecedented supply chain unpredictability.
March 10, 2026
The Path & The Practice
Episode 133: Casey Knapp, Partner
This episode of The Path & The Practice features a conversation with Marshall Keen, a summer associate in Foley’s Dallas office.
March 10, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About…Managing the Aftermath of the Supreme Court’s IEEPA Tariff Decision (Part II)
On February 20, 2026, the U.S. Supreme Court issued its long-anticipated decisions in Learning Resources, Inc. v. Trump, and the consolidated case Trump v. V.O.S. Selections, Inc., holding that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose broad-based tariffs.